case_images: PMC10766420_01
case_images: CT scan before treatment for hepatocellular carcinoma. a Early phase. b Late phase. Multiple nodules in the liver, including a nodule up to 10 cm in the right lobe (yellow arrowheads).
case_images: crg-2024-0018-0001-535476_F01.jpg
case_images: PMC10766420_01_crg-2024-0018-0001-535476_F01.jpg
case_images: F1
case_images: Enhanced computed tomography revealed multiple nodules with contrast enhancement in both lobes of her liver, including a nodule up to 10 cm in the right lobe (shown in Fig. 1a, b).
case_images: CT scan performed at symptom onset. a Early phase. b Late phase. No findings of fever but hepatocellular carcinoma shrank to 9 cm (yellow arrowheads).
case_images: crg-2024-0018-0001-535476_F02.jpg
case_images: PMC10766420_01_crg-2024-0018-0001-535476_F02.jpg
case_images: F2
case_images: A computed tomography scan revealed the HCC had shrunk to 9 cm, but the reason for fever was not evident, excluding pneumonitis, cholangitis, and enterocolitis (shown in Fig. 2a, b).
case_images: Contrast-enhanced FLAIR MRI of the brain. a Imaging before steroid treatment revealing contrast enhancement along the cerebral sulcus (red arrowheads). b Image taken 8 days after commencing steroid treatment indicating the contrast effect along the cerebral sulcus disappeared.
case_images: crg-2024-0018-0001-535476_F03.jpg
case_images: PMC10766420_01_crg-2024-0018-0001-535476_F03.jpg
case_images: F3
case_images: Contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging revealed contrast enhancement along the cerebral sulcus (shown in Fig. 3a). The contrast effect along the cerebral sulcus had disappeared from fluid-attenuated inversion recovery magnetic resonance imaging by 8 days after commencing prednisolone treatment (shown in Fig. 3b).